drugset / Trial / NCT00683436
Efficacy and Safety Study of Adipiplon, Placebo and an Active Control in Primary Insomniacs
RandomizedCrossoverTriple-blindTreatment
Summary
This will be a multi-center, randomized, blinded, comparative, placebo-controlled, 4 arm crossover study in patients with primary insomnia.
Timeline
- Start
- 2008-05
- Primary completion
- 2008-10
- Completion
- 2008-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Adipiplon | Small molecule | 6 mg | — |
| Subject | Adipiplon | Small molecule | 9 mg | — |
| Subject | Zolpidem | Small molecule | 12.5 mg | — |